Intranasal nerve growth factor for prevention and recovery of the outcomes of traumatic brain injury
Traumatic brain injury is one of the main causes of mortality and disability worldwide. Traumatic brain injury is characterized by a primary injury directly induced by the impact, which progresses into a secondary injury that leads to cellular and metabolic damages, starting in the first few hours a...
Main Authors: | Luigi Manni, Giorgio Conti, Antonio Chiaretti, Marzia Soligo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=4;spage=773;epage=778;aulast=Manni |
Similar Items
-
Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma
by: Luigi Manni, et al.
Published: (2021-11-01) -
Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome
by: Antonio Gatto, et al.
Published: (2023-10-01) -
Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties
by: Jignesh D. Pandya, et al.
Published: (2024-02-01) -
Recent Developments In Brain-Targeted Drug Delivery Systems via Intranasal Route
by: Ahmad Ainurofiq, et al.
Published: (2023-05-01) -
Long-Term Intranasal Nerve Growth Factor Treatment Favors Neuron Formation in de novo Brain Tissue
by: Nina Colitti, et al.
Published: (2022-07-01)